Brazil’s stock market is surging, but the companies behind it are under mounting strain. The Ibovespa has soared more than any other major index in the Americas over the past year, rising almost 60% in dollar terms, even as borrowing costs hover near a two-decade peak and credit grows harder to find.
The latest sign came last week, when hospital operator Kora Saude Participacoes filed for an out-of-court debt restructuring. Weeks earlier, biofuels producer Raizen and supermarket chain Companhia Brasileira de Distribuicao had suffered the same fate, underscoring how deep the pressure has become across corporate Brazil. The market’s strength looks impressive on the surface, but it is masking a broader debt problem that is forcing a historically high number of companies to fight to keep their doors open.
That gap between financial-market optimism and corporate reality is what makes Brazil stand out now. Investors have pushed the Ibovespa sharply higher, yet the cost of borrowing remains punishing and new credit is increasingly scarce. For many firms, that combination leaves debt relief not as a last resort but as the only workable path to stay in business.
The tension is that the market’s rally and the corporate distress are happening at the same time. A strong index can suggest resilience, but the sequence of restructurings shows how fragile that picture is once the focus shifts from share prices to balance sheets. The problem is no longer confined to one industry or one company. It is spreading through a corporate sector that is already under heavy strain.
For now, the Ibovespa’s gains are real. So are the debts. The question for Brazil’s companies is not whether the market looks healthy, but how many more will need restructuring before that strength reaches the rest of the economy.
